[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521458":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":50,"locations":25,"responsibleParty":57,"collaborators":60,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":25,"enrollmentInfo":79,"targetDuration":25,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":94,"whyStopped":25,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":25},{"fullName":5,"class":6},"George Washington University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"MMS with 60 mg of iron first, then IFA with 60 mg of iron","EXPERIMENTAL","Women will receive the first regimen (MMS with 60 mg of iron) for 2 months and then crossover on to the second regimen (IFA with 60 mg of iron) for 2 months",[13,14],"Dietary Supplement: Iron Folic Acid Tablets with 60 mg of iron","Dietary Supplement: Multiple Micronutrient Supplements with 60 mg of elemental iron",{"label":16,"type":10,"description":17,"interventionNames":18},"IFA with 60 mg of iron first, then MMS with 60 mg of iron","Women will receive the first regimen (IFA with 60 mg of iron) for 2 months and then crossover on to the second regimen (MMS with 60 mg of iron) for 2 months",[13,14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Iron Folic Acid Tablets with 60 mg of iron","IFA with 60 mg iron is an intervention group. IFA with 60 mg of iron will be taken orally once daily from the time of randomization",[16,9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Multiple Micronutrient Supplements with 60 mg of elemental iron","MMS with 60 mg iron is an intervention group. MMS with 60 mg of iron plus standard UNIMMAP formulation for other 14 micronutrients will be taken orally once daily from the time of randomization.",[16,9],[31,35,38,41,44,47],{"name":32,"affiliation":33,"role":34},"Blair Wylie, MD, MPH","Columbia University","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":37,"role":34},"Honorati Masanja, PhD","Ifakara Health Institute",{"name":39,"affiliation":40,"role":34},"Alfa Muhihi, PhD","Africa Academy of Public Health",{"name":42,"affiliation":43,"role":34},"Andrea Pembe, MD, MMed, PhD, FCOG","Muhimbili University of Health and Allied Sciences",{"name":45,"affiliation":46,"role":34},"Emily R Smith, ScD, MPH","The George Washington University",{"name":48,"affiliation":49,"role":34},"Christopher R Sudfeld, ScD, ScM","Harvard University",[51,55],{"name":45,"role":52,"phone":53,"phoneExt":25,"email":54},"CONTACT","202-994-3589","emilysmith@gwu.edu",{"name":48,"role":52,"phone":25,"phoneExt":25,"email":56},"csudfeld@hsph.harvard.edu",{"type":34,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Emily Smith","Principal Investigator",[61,62,64,65,67],{"name":37,"class":6},{"name":63,"class":6},"Harvard School of Public Health (HSPH)",{"name":43,"class":6},{"name":66,"class":6},"Africa Academy for Public Health",{"name":33,"class":6},"100521458","phase-3-multiple-micronutrient-supplementation-mms-vs-ifa-acceptability-crossover-trial-100521458",false,"NCT06069856","Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial","Individually Randomized Crossover Trial of Multiple Micronutrient Supplementation (MMS) Versus IFA During Pregnancy in Tanzania","MIFA-ACT","Inclusion Criteria:\n\n* Attending first ANC visit at the study clinic\n* Pregnant women ≤ 15 weeks of gestation\n* Aged ≥ 18 years\n* Intending to stay in the study area for the duration of study\n* Provides informed consent\n\nExclusion Criteria:\n\n* Severe anemia (defined as Hb \\\u003C8.5 g\u002FdL per Tanzania standard of care)\n* Sickle cell disease (SS,SC, CC genotype) as tested by HemoTypeSC\n* Concurrent participation in other nutritional supplementation trial\n* Pregnant women with disability or condition which would impair their ability to provide informed consent and complete study procedures.",true,"FEMALE","18 Years",{"count":80,"type":81},130,"ESTIMATED","INTERVENTIONAL",[84],"PHASE3","This is an open-label individually randomized mixed methods cross-over trial to assess acceptability, preference, and side effects of IFA formulations with 60 mg of iron to MMS formulations with 60 mg of iron.",[87],"Pregnancy Related",[89,90,91,92,93],"Acceptability","Multiple Micronutrient Supplementation","Iron","IFA","Tanzania","NOT_YET_RECRUITING","2026-06-03",{"date":97,"type":98},"2026-06-04","ACTUAL",{"date":100,"type":81},"2027-06-01",{"date":102,"type":81},"2027-12",{"name":5,"class":6}]